Items where Author is "Rothery, Claire"
Jump to: Restricted | Public
Number of items: 3.
Restricted
WOODS, Beth, KEARNS, Ben, SCHMITT, Laetitia, JANKOVIC, Dina, ROTHERY, Claire, HARNAN, Sue, HAMILTON, Jean, SCOPE, Alison, REN, Shijie, BOJKE, Laura, WILCOX, Mark, HOPE, William, LEONARD, Colm, HOWARD, Philip, JENKINS, David, ASHWORTH, Alan, BENTLEY, Andrew and SCULPHER, Mark
(2025).
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England.
Applied Health Economics and Health Policy, 23 (1), 5-17.
[Article]
Public
HARNAN, Sue, KEARNS, Ben, SCOPE, Alison, SCHMITT, Laetitia, JANKOVIC, Dina, HAMILTON, Jean, SRIVASTAVA, Tushar, HILL, Harry, KU, Chu Chang, REN, Shijie, ROTHERY, Claire, BOJKE, Laura, SCULPHER, Mark and WOODS, Beth
(2024).
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Health technology assessment (Winchester, England), 28 (73), 1-230.
[Article]
WOODS, Beth, SCHMITT, Laetitia, JANKOVIC, Dina, KEARNS, Benjamin, SCOPE, Alison, REN, Shijie, SRIVASTAVA, Tushar, KU, Chu Chang, HAMILTON, Jean, ROTHERY, Claire, BOJKE, Laura, SCULPHER, Mark and HARNAN, Sue
(2024).
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Health technology assessment (Winchester, England), 28 (28), 1-238.
[Article]